Palmer R N, Gralnick H R
Blood. 1982 Jan;59(1):38-42.
Studies of the prothrombin time (PT) have revealed that contact with borosilicate or commercial siliconized borosilicate markedly shortens the PT. This shortening is related to the activation of the contact phase of blood coagulation. This shortening of the PT occurs in both normal whole blood and plasma when stored in borosilicate or siliconized borosilicate tubes at 4 degree C and to a lesser degree at room temperature. Studies indicated the importance of several coagulation factors in decreasing the PT. The PT did not change in blood deficient in factor XII or in plasma deficient in Fletcher factor or high molecular weight kininogen, while blood deficient in CI esterase inhibitor (CI INH) had the most profound shortening. Shortening of the PT correlated directly with increased levels of factor VII. When purified CI INH was added to normal blood, it markedly reduced the activation of factor VII and the shortening of the PT in a dose-related manner. These studies indicate the pivotal roles of the contact phase of coagulation in initiating activation of the PT and of CI INH in inhibiting the activation of the coagulation factor(s) responsible for the cold-promoted activation of factor VII.
凝血酶原时间(PT)研究表明,与硼硅酸盐或商业化硅化硼硅酸盐接触会显著缩短PT。这种缩短与凝血接触相的激活有关。当正常全血和血浆在4℃下储存在硼硅酸盐或硅化硼硅酸盐试管中时,PT会缩短,在室温下缩短程度较小。研究表明几种凝血因子在降低PT方面的重要性。缺乏因子 XII 的血液或缺乏 Fletcher 因子或高分子量激肽原的血浆中PT不变,而缺乏 C1 酯酶抑制剂(C1 INH)的血液中PT缩短最为显著。PT的缩短与因子 VII 水平升高直接相关。当将纯化的 C1 INH 添加到正常血液中时,它以剂量相关的方式显著降低因子 VII 的激活和PT的缩短。这些研究表明凝血接触相在启动PT激活中的关键作用,以及C1 INH在抑制负责因子 VII 冷促进激活的凝血因子激活中的关键作用。